{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:57:31Z","timestamp":1738666651635,"version":"3.36.0"},"reference-count":12,"publisher":"Scientific Foundation Spiroski (publications)","issue":"2","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>AIM: Compare itraconazole alone, fluconazole combined with ketoconazole and ketoconazole in the treatment of patients with pityriasis versicolor.\r\nMATERIAL AND METHODS: A group of 240 pityriasis versicolor patients (confirmed with KOH and culture) were classified into 3 groups: Fluconazole 300 mg a week and 2% ketoconazole foam twice a week for 2 weeks (Category I), Itraconazole 200 mg daily for one week (category II); Ketoconazole 2% foam daily for 2 weeks (Category 3). Clinical (colour of macule, scale, pruritus) and mycological assessment were done after 4 weeks of therapy.\r\nRESULTS: After 4 weeks of treatment, clinical cure was observed in 62.4% (Category I), 36.3% (Category II) and 37.5% (Category III).\r\nCONCLUSION: It was reported in our study that the most effective regimen for PV patients is fluconazole 300 mg per week combined with ketoconazole 2% twice a week for 2 weeks.<\/jats:p>","DOI":"10.3889\/oamjms.2019.092","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T08:43:08Z","timestamp":1548751388000},"page":"272-274","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor"],"prefix":"10.3889","volume":"7","author":[{"given":"Van Tran","family":"Cam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuong","family":"Nguyen Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khang","family":"Tran Hau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doanh","family":"Le Huu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong Pham","family":"Thi Minh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sau","family":"Nguyen Huu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thu","family":"Nguyen Minh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gandolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Satolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Feliciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheal","family":"Tirant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Vojvodic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torello","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"52292","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"62409","doi-asserted-by":"crossref","unstructured":"Prohic A, Jovovic-Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S . Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 2016; 55(5):494-504. https:\/\/doi.org\/10.1111\/ijd.13116 PMid:26710919","DOI":"10.1111\/ijd.13116"},{"key":"62410","unstructured":"Badri T, Hammami H, Bzioueche N, Zouari B, Mokhtar I. Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasisversicolor. Tunis Med. 2016;94(2):107-111. PMid:27532525"},{"key":"62411","doi-asserted-by":"crossref","unstructured":"Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasisversicolor: results of a prospective, multicentre, randomised study. Mycoses. 2008; 51(6):532-535. https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01508.x PMid:18422916","DOI":"10.1111\/j.1439-0507.2008.01508.x"},{"key":"62412","doi-asserted-by":"crossref","unstructured":"Karakas M, Durdu M, Memisoglu HR. Oral fluconazole in the treatment of tineaversicolor. J Dermatol. 2005; 32(1):19-21. https:\/\/doi.org\/10.1111\/j.1346-8138.2005.tb00707.x PMid:15841655","DOI":"10.1111\/j.1346-8138.2005.tb00707.x"},{"key":"62413","doi-asserted-by":"crossref","unstructured":"Kokturk A, Kaya TI, Ikizoglu G, Bugdayci R, Koca A. Efficacy of three short-term regimens of itraconazole in the treatment of pityriasisversicolor. J Dermatolog Treat. 2002; 13(4):185-187. https:\/\/doi.org\/10.1080\/09546630212345676 PMid:19753739","DOI":"10.1080\/09546630212345676"},{"key":"62414","doi-asserted-by":"crossref","unstructured":"Rigopoulos D, Gregoriou S, Kontochristopoulos G, Ifantides A, Katsambas A. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasisversicolor. A randomised double-blind comparative trial. Mycoses. 2007; 50(3):193-195. https:\/\/doi.org\/10.1111\/j.1439-0507.2006.01352.x PMid:17472615","DOI":"10.1111\/j.1439-0507.2006.01352.x"},{"key":"62415","unstructured":"Cantrell WC, ElewksiBE. Can pityriasisversicolor be treated with 2% ketoconazole foam? J Drugs Dermatol. 2014; 13(7):855-859. PMid:25007370"},{"key":"62416","doi-asserted-by":"crossref","unstructured":"Shi TW, Zhang JA, Tang YB, Yu HX, Li ZG, Yu JB. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasisversicolor. J Dermatolog Treat. 2015; 26(2):143-146. https:\/\/doi.org\/10.3109\/09546634.2014.921661 PMid:24802530","DOI":"10.3109\/09546634.2014.921661"},{"key":"62417","unstructured":"Mohanty J, Sethi J, Sharma M. Efficacy of itraconazole in the treatment of tineaversicolor. Indian J Dermatol Venereol Leprol. 2001; 67(5):240-241. PMid:17664760"},{"key":"62418","doi-asserted-by":"crossref","unstructured":"Kose O, BulentTastan H, RizaGur A, Kurumlu Z. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tineaversicolor. J Dermatolog Treat. 2002;13(2):77-79. https:\/\/doi.org\/10.1080\/095466302317584430 PMid:12060506","DOI":"10.1080\/095466302317584430"},{"key":"62419","unstructured":"Mohanty J, Sethi J, Sharma M. Efficacy of itraconazole in the treatment of tineaversicolor. Indian J Dermatol Venereol Leprol. 2001; 67(5):240-241. PMid:17664760"},{"key":"62420","doi-asserted-by":"crossref","unstructured":"Chokoeva AA, Wollina U, Lotti T, Maximov GK, Lozev I, Tchernev G. Psoriasiform Dermatophytosis in a Bulgarian Child. Open Access Maced J Med Sci. 2018; 6(1):118-119. https:\/\/doi.org\/10.3889\/oamjms.2018.009 PMid:29484004 PMCid:PMC5816278","DOI":"10.3889\/oamjms.2018.009"}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2019.092\/2836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2019.092\/2872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T08:41:46Z","timestamp":1692520906000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2019.092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,30]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2019.092","relation":{},"ISSN":["1857-9655"],"issn-type":[{"type":"electronic","value":"1857-9655"}],"subject":[],"published":{"date-parts":[[2019,1,28]]}}}